Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. - Wikidata - wikimedia - TriplyDB

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

http://www.wikidata.org/entity/Q37133224

about

Therapeutic Approach to Adult Fibrotic Lung Diseases Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?Managing comorbidities in idiopathic pulmonary fibrosis A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases.Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.Diagnosis and management of interstitial lung disease.Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.Advances in the treatment of idiopathic pulmonary fibrosis.Comprehensive Care of the Lung Transplant Patient.Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis.Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?Venous Thromboembolism After Adult Lung Transplantation: A Frequent Event Associated with Lower Survival.Relative Risk of Deep Vein Thrombosis in Very Elderly Patients Compared With Elderly Patients.Depression in patients with idiopathic pulmonary fibrosis.Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis.An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.Suspected pulmonary embolism in patients with pulmonary fibrosis: Discordance between ventilation/perfusion SPECT and CT pulmonary angiography.

P2860

Q26741569-552BA4EC-CF48-45D2-9285-F3B606604484 Q26781677-63C7A0E2-2932-4619-B2AA-3EB649D7E041 Q26785617-BC86E2AB-E25B-453D-9F3D-267309103561 Q28266119-D7C6634C-6E35-4393-9E43-56B9C044B431 Q34570130-F627C39D-A0B9-4981-B2A8-6C4C7A8DE344 Q35158964-3F8A521E-29B2-4279-922C-45FEF41FB510 Q37237739-E0ED9973-E3E9-49AE-8B18-08EB5F0CC8D2 Q37334817-E0EA8578-A598-408A-90F2-B3F54C4E2BCB Q38247265-00EC5625-5A19-42AF-89F8-F36C27C2E0C7 Q38288028-C9DAEBBB-8F16-43CA-B145-F49F24866919 Q38616538-87DD25CE-9381-48CA-9DB9-EE62F50C80E5 Q38656594-320D7F04-27EE-4C7C-A5CA-B523C3F068FE Q38978203-188475F4-82C7-412C-9123-E6FD6C8B8DBF Q39587123-E181CCDD-1E0A-4D63-B2BE-44DD058F34EF Q46345217-65A8DE16-C3A1-4147-B77B-C1F1AFDA5CA7 Q47230370-9561BDD4-9C34-491F-A0FA-501CEB1740E7 Q47747723-DF468068-8571-4A8C-A3C7-C662E8994F79 Q48101488-9FC96C5C-9338-4B2D-8CC8-63D1BC42F3A7 Q48444309-35E911F6-5CC2-428E-9FF8-55F13E299F96 Q51565969-D9426ADA-8CE7-48E8-B1E1-8F64B27D8C6E Q51612566-3E77F724-9905-4496-BE08-8FA78F752AF1 Q52983747-B5150A3E-68AC-4640-9DBD-FB98E4C33D6C

P2860

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

http://www.wikidata.org/entity/Q37133224

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@en

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@nl

type

label

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@en

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@nl

prefLabel

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@en

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@nl

P1433

Q37133224-EB75D6F3-A032-4C84-A82B-09CEB2A3E6DC

P1476

Q37133224-9F2FD209-E953-40B6-BF40-E66C4992A820

P2093

Q37133224-26C40CBC-7B75-4271-9428-160C6A115E23

Q37133224-64DE0ED3-751B-4B01-A428-953E2528C054

Q37133224-A67ACB83-884B-46B4-9FD2-B94D750A95BD

Q37133224-B923CD2C-4144-470E-8312-746D17C3B481

Q37133224-C491E75C-503C-4EA0-99C3-9210D2452415

Q37133224-C501A8E6-81AC-4774-B346-EFF663B5FFBB

Q37133224-CF37FE2E-064B-41AE-B739-EE37A9C914B6

Q37133224-DC2845CD-2F78-4693-BA52-EFF2D535C9A0

P2860

Q37133224-157725F3-2AAB-4658-B3BB-174CBCE20971

Q37133224-1B25BADC-150A-47FC-8DDD-46A4102F6682

Q37133224-2434307F-023B-4B80-9F97-E685EDBF21B5

Q37133224-29139C95-EB03-419F-913F-DECFD82BDC09

Q37133224-3626436E-A188-4175-ACD1-3F4B7CB0436C

Q37133224-435EDD3E-44EF-4C98-A725-0F845B678705

Q37133224-471FC209-AA78-499B-8222-8AF27AF50D98

Q37133224-488D2E51-DEED-4E06-9367-CA8C816989C0

Q37133224-52D0402B-FBF4-4092-9E17-253158A8CB82

Q37133224-5D0D6B55-D367-4B59-BA4F-F9ADEA9659B0

P304

Q37133224-B2C35E83-D992-48F7-89A6-9E24B4958D22

P31

Q37133224-12C02B77-931A-4EB0-906E-D0C30521A170

P356

Q37133224-42A25BC0-4BF4-4D19-8D44-B74EA3AA5E04

P433

Q37133224-A5E1E0B9-175B-43B0-BFA0-83BE994F35E2

P478

Q37133224-71C7704F-456C-49ED-838E-7EC947AEB1F5

P577

Q37133224-2CCF44A7-F480-4BB6-8448-405B7FD71973

P5875

Q37133224-FE9E33DF-9D1E-4B96-B9AC-331A49AAA1A3

P698

Q37133224-0CEED1D5-0CB2-41C4-9EED-44E37C6E6088

P921

Q37133224-2D132225-B22B-46E2-9B69-07D42BEA5423

Q37133224-CB577076-C067-47BB-9141-667DF0DB5B6B

P932

Q37133224-11F61237-0C91-4D65-BAD3-CE4A9ECFE482

P356

09031936.00041411

P1433

European Respiratory Journal

P1476

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.

@en

P2093

A Fischer

http://www.w3.org/2001/XMLSchema#string

A L Olson

http://www.w3.org/2001/XMLSchema#string

D B Sprunger

http://www.w3.org/2001/XMLSchema#string

E R Fernandez-Perez

http://www.w3.org/2001/XMLSchema#string

J J Solomon

http://www.w3.org/2001/XMLSchema#string

J J Swigris

http://www.w3.org/2001/XMLSchema#string

K K Brown

http://www.w3.org/2001/XMLSchema#string

T J Huie

http://www.w3.org/2001/XMLSchema#string

P2860

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

Incidence and prevalence of idiopathic pulmonary fibrosis.

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

The epidemiology of venous thromboembolism.

Rising mortality from cryptogenic fibrosing alveolitis.

Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

Acute exacerbations of idiopathic pulmonary fibrosis

Mortality rates from cryptogenic fibrosing alveolitis in seven countries.

Accuracy of mortality data for interstitial lung diseases in New Mexico, USA

P304

125-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00041411

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51475346

http://www.w3.org/2001/XMLSchema#string

P698

21737559

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

thromboembolism

P932

3757572

http://www.w3.org/2001/XMLSchema#string